World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 81 1537 1397 133 126 309 35050
Medicine 81 16405 15430 1494 1428 319 35646

Robert E. Hawkins publications per year

The chart shows the history of publications by Robert E. Hawkins between 1986 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Robert E. Hawkins published across 40 years, from 1986 to 2025, averaging 9 papers a year. Output peaked at 36 publications in 2023. 3 of the 361 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1986 to 2025. Vertical axis: number of publications, 0 to 36. Peak 36 publications in 2023. 1986: 1 publication 1987: 0 publications 1988: 0 publications 1989: 2 publications 1990: 2 publications 1991: 0 publications 1992: 8 publications 1993: 4 publications 1994: 11 publications 1995: 6 publications 1996: 7 publications 1997: 4 publications 1998: 5 publications 1999: 4 publications 2000: 2 publications 2001: 2 publications 2002: 8 publications 2003: 7 publications 2004: 15 publications 2005: 24 publications 2006: 21 publications 2007: 11 publications 2008: 19 publications 2009: 16 publications 2010: 16 publications 2011: 16 publications 2012: 14 publications 2013: 10 publications 2014: 21 publications 2015: 11 publications 2016: 11 publications 2017: 7 publications 2018: 10 publications 2019: 8 publications 2020: 7 publications 2021: 10 publications 2022: 2 publications 2023: 36 publications 2024: 1 publication 2025: 2 publications
1986 2025

361 publications in total across all disciplines

View publications per year as a table
Robert E. Hawkins: publications per year, 1986 to 2025
Year Publications
1986 1
1987 0
1988 0
1989 2
1990 2
1991 0
1992 8
1993 4
1994 11
1995 6
1996 7
1997 4
1998 5
1999 4
2000 2
2001 2
2002 8
2003 7
2004 15
2005 24
2006 21
2007 11
2008 19
2009 16
2010 16
2011 16
2012 14
2013 10
2014 21
2015 11
2016 11
2017 7
2018 10
2019 8
2020 7
2021 10
2022 2
2023 36
2024 1
2025 2
Total 361
Download as CSV

Robert E. Hawkins publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert E. Hawkins sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 302–311 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 309 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95 309
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Robert E. Hawkins D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert E. Hawkins sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 80–81 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121 81
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Robert E. Hawkins is affiliated with the University of Manchester in the United Kingdom. Their research spans multiple disciplines within computer science and biology, with significant contributions in artificial intelligence and molecular biology. Hawkins's body of work includes publications in experimental and cognitive psychology, oncology, and pulmonary and respiratory medicine.

The main fields of study for Hawkins include:

  • Computer Science

The subfields covered by their research are:

  • Artificial Intelligence
  • Molecular Biology
  • Experimental and Cognitive Psychology
  • Oncology
  • Pulmonary and Respiratory Medicine

Hawkins's research interests encompass a range of topics, including:

  • Topic Modeling
  • Speech and dialogue systems
  • Language and cultural evolution
  • Language, Metaphor, and Cognition
  • Renal cell carcinoma treatment
  • Natural Language Processing Techniques
  • CAR-T cell therapy research

Frequently collaborating with various scholars, Hawkins has worked with:

  • Thomas L. Griffiths
  • Noah D. Goodman
  • Theodore R. Sumers
  • Mark K. Ho
  • Michael Franke

Their publications have appeared mostly in several venues, with notable repetition in:

  • arXiv (Cornell University)
  • Regular and Young Investigator Award Abstracts
  • Psychological Review
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cognitive Science

Recent papers authored or co-authored by Hawkins include:

  • "Atezolizumab plus Bevacizumab Versus Sunitinib for Patients with Untreated Metastatic Renal Cell Carcinoma and Sarcomatoid Features: A Prespecified Subgroup Analysis of the IMmotion151 Clinical Trial," 2020, European Urology
  • "From partners to populations: A hierarchical Bayesian account of coordination and convention," 2022, Psychological Review
  • "Extracellular vesicles incorporating retrovirus-like capsids for the enhanced packaging and systemic delivery of mRNA into neurons," 2024, Nature Biomedical Engineering
  • "A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma," 2021, Clinical Genitourinary Cancer
  • "Shared functional specialization in transformer-based language models and the human brain," 2024, Nature Communications

Hawkins has also contributed to book publications, including a title published by The MIT Press:

  • Experimentology, anticipated in 2025

Best Publications

  • Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

    Robert J Motzer;Nizar M Tannir;David F McDermott;Osvaldo Arén Frontera

  • Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

    Brian I. Rini;Elizabeth R. Plimack;Viktor Stus;Rustem Gafanov

  • Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

    Cora N. Sternberg;Ian D. Davis;Jozef Mardiak;Cezary Szczylik

  • Making Antibodies by Phage Display Technology

    Greg Winter;Andrew D. Griffiths;Robert E. Hawkins;Hennie R. Hoogenboom

  • Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

    Robert J. Motzer;Thomas E. Hutson;David Cella;James Reeves

  • Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

    Brian I Rini;Thomas Powles;Michael B Atkins;Bernard Escudier

  • Selection of phage antibodies by binding affinity. Mimicking affinity maturation.

    Robert E. Hawkins;Stephen J. Russell;Greg Winter

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

    Cora N. Sternberg;Robert E. Hawkins;John Wagstaff;Pamela Salman

  • Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study

    Bernard Escudier;Camillo Porta;Petri Bono;Thomas Powles

  • Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

    Andrew J Armstrong;Susan Halabi;Tim Eisen;Samuel Broderick

  • The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity.

    Fiona C. Thistlethwaite;Fiona C. Thistlethwaite;David E. Gilham;Ryan D. Guest;Dominic G. Rothwell

  • The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens.

    Ryan D Guest;Robert E Hawkins;Natalia Kirillova;Eleanor J Cheadle

  • Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial

    S R Bramhall;M T Hallissey;J Whiting;J Scholefield

  • Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library.

    R.H.J. Begent;M.J. Verhaar;K.A. Chester;J.L. Casey

  • The optimal antigen response of chimeric antigen receptors harboring the CD3zeta transmembrane domain is dependent upon incorporation of the receptor into the endogenous TCR/CD3 complex.

    John S Bridgeman;Robert E Hawkins;Steven Bagley;Morgan Blaylock

  • Retroviral vectors displaying functional antibody fragments

    Stephen J. Russell;Robert E. Hawkins;Greg Winter

  • Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma

    Christy Ralph;Eyad Elkord;Deborah J. Burt;Jackie F. O'Dwyer

  • The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes.

    Robert E. Hawkins;John B. Schofield;Cyril Fisher;Eve Wiltshaw

  • CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe.

    David E. Gilham;Reno Debets;Martin Pule;Robert E. Hawkins

Frequent Co-Authors

Peter L. Stern
Peter L. Stern University of Manchester
Camillo Porta
Camillo Porta University of Bari Aldo Moro
Eyad Elkord
Eyad Elkord Xi’an Jiaotong-Liverpool University
Thomas Powles
Thomas Powles Queen Mary University of London
Cora N. Sternberg
Cora N. Sternberg Cornell University
Stéphane Oudard
Stéphane Oudard Hôpital Européen Georges-Pompidou
Brian I. Rini
Brian I. Rini Vanderbilt University Medical Center
Alain Ravaud
Alain Ravaud University of Bordeaux
Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related healthcare degrees online can open diverse career pathways. Many students start with foundational programs like online adn programs for non nurses, designed for individuals transitioning into nursing without prior experience. These programs provide essential clinical skills while accommodating working professionals.

If you’re aiming for a quicker route to become a registered nurse, easiest accelerated nursing programs to get into offer streamlined curricula that prepare students for licensure in less time. Such degrees can be an ideal stepping stone toward advanced immunology-related roles.

For those seeking entry-level opportunities, lpn programs easy to get into provide foundational training with flexible admission standards. Licensed Practical Nurses often work closely with immunologists and healthcare teams, gaining valuable experience in patient care.

Advancing further, many explore what is the easiest np program to find nurse practitioner degrees with manageable prerequisites. Becoming a Nurse Practitioner expands clinical responsibilities and opportunities to specialize in immunology-focused healthcare settings.

Best Scientists Citing Robert E. Hawkins

Trending Scientists

Recently Published Articles